Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCom.int.bk.regs Regulatory News (CBKD)

Share Price Information for Com.int.bk.regs (CBKD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.494
Bid: 1.472
Ask: 1.506
Change: -0.006 (-0.40%)
Spread: 0.034 (2.31%)
Open: 1.53
High: 1.53
Low: 1.462
Prev. Close: 1.50
CBKD Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

CIB FY2020 Annual Financial Report

29 Apr 2021 10:09

RNS Number : 0559X
Commercial Intnl Bank (Egypt) SAE
29 April 2021
 

Click on, or paste the following link into your web browser, to view the associated PDF document

http://www.rns-pdf.londonstockexchange.com/rns/0559X_1-2021-4-29.pdfhttp://www.rns-pdf.londonstockexchange.com/rns/0559X_2-2021-4-29.pdfhttp://www.rns-pdf.londonstockexchange.com/rns/0559X_3-2021-4-29.pdfhttp://www.rns-pdf.londonstockexchange.com/rns/0559X_4-2021-4-29.pdfhttp://www.rns-pdf.londonstockexchange.com/rns/0559X_5-2021-4-29.pdf

 

 

 

 

 

 

 

Commercial International Bank (Egypt) S.A.E.

Financial Statements

December 31, 2020

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

               

Consolidated Income Statement for the Year Ended December 31, 2020

 

 

 

 

 

 

 

 

 

 

 

Notes

 

 

Dec. 31, 2020

 

 

 

Dec. 31, 2019

 

 

 

 

EGP Thousands

 

 

 

EGP Thousands

 

 

 

 

 

 

 

 

 

Interest and similar income

 

 

 

42,196,235

 

 

 

42,600,957

Interest and similar expense

 

 

 

(17,107,598)

 

 

 

(21,054,078)

Net interest income

3

 

 

25,088,637

 

 

 

21,546,879

 

 

 

 

 

 

 

 

 

Fee and commission income

 

 

 

3,059,264

 

 

 

3,451,688

Fee and commission expense

 

 

 

(983,450)

 

 

 

(1,170,893)

Net fee and commission income

4

 

 

2,075,814

 

 

 

2,280,795

 

 

 

 

 

 

 

 

 

Dividend income

5

 

 

50,175

 

 

 

53,423

Net trading income

6

 

 

483,006

 

 

 

688,059

Profits (Losses) on financial investments

20

 

 

1,001,958

 

 

 

450,697

Administrative expenses

7

 

 

(6,877,303)

 

 

 

(6,468,560)

Other operating expenses

8

 

 

(2,500,823)

 

 

 

(1,698,547)

Impairment release (charges) for credit losses

9

 

 

(5,018,781)

 

 

 

(1,435,460)

Intangible Assets Impairment

 

 

 

-

 

 

 

(651,041)

Profits from subsidiaries acquisition

38

 

 

8,086

 

 

 

-

Bank's share in the profits of associates

12

 

 

22,426

 

 

 

1,135

Profit before income tax from continuing operations

 

 

14,333,195

 

 

 

14,767,380

 

 

 

 

 

 

 

 

 

Current income tax expense

 

 

 

(5,087,418)

 

 

 

(4,639,364)

Deferred income tax

10.2

 

 

87,433

 

 

 

(94,522)

Net profit from continuing operations

 

 

 

9,333,210

 

 

 

10,033,494

 

 

 

 

 

 

 

 

 

Net profit for the year

 

 

 

9,333,210

 

 

 

10,033,494

 

 

 

 

 

 

 

 

 

Attributable to:

 

 

 

 

 

 

 

 

Equity holders of the parent

 

 

 

9,335,044

 

 

 

10,033,494

Non-controlling interest

 

 

 

(1,834)

 

 

 

-

Net Profit for the year

 

 

 

9,333,210

 

 

 

10,033,494

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earning per share

11

 

 

 

 

 

 

 

Basic attributable to equity holders of the parent

 

 

 

6.36

 

 

 

6.84

Diluted attributable to equity holders of the parent

 

 

 

6.33

 

 

 

6.81

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The accompying notes from 1 to 42 form an integral part of these consolidated financial statements.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Hussein Abaza

 

 

 

Sherif Samy

CEO & Board member

 

 

 

Chairman

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated Statement of Comprehensive Income for the Year Ended December 31, 2020

 

 

 

 

 

 

 

 

 

 

 

 

Dec. 31, 2020

 

 

Dec. 31, 2019

 

 

 

 

 

EGP Thousands

 

 

EGP Thousands

 

 

Profit for the year

 

 

9,333,210

 

 

10,033,494

 

 

Other comprehensive income to be reclassified to profit or loss in subsequent periods:

 

 

 

 

 

 

 

 

Net (Loss)/gain on FVOCI

 

 

(295,452)

 

 

5,975,133

 

 

Total other comprehensive income for the year

 

 

9,037,758

 

 

16,008,627

 

 

 

 

 

 

 

 

 

 

 

Attributable to:

 

 

 

 

 

 

 

 

Equity holders of the parent

 

 

9,039,592

 

 

16,008,627

 

 

Non-controlling interest

 

 

(1,834)

 

 

-

 

 

 

 

 

 

 

 

 

 

 

The accompying notes from 1 to 42 form an integral part of these consolidated financial statements.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated Statement of Financial Position as at December 31, 2020

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Notes

Dec. 31, 2020

 

Dec. 31, 2019

 

EGP Thousands

 

EGP Thousands

Assets

 

 

 

 

Cash and balances at the central bank

13

33,768,549

 

28,273,962

Due from banks

14

87,426,301

 

28,353,366

Loans and advances to banks, net

15

776,980

 

625,264

Loans and advances to customers, net

16

119,570,005

 

119,321,103

Financial Assets at Fair value through P&L

19

552,288

 

545,545

Derivative financial instruments

17

248,759

 

216,383

Financial Assets at Fair value through OCI

19

156,157,553

 

92,940,479

Financial Assets at Amortized cost

19

25,285,225

 

107,225,613

Right of use

23

814,587

 

339,501

Investments in associates

21

139,871

 

107,693

Other assets

22

9,175,525

 

9,748,143

Intangible assets

38

51,831

 

-

Goodwill

38

206,287

 

-

Deferred tax assets

10.2

437,772

 

350,339

Property and equipment

23

2,311,147

 

2,204,464

Total assets

 

436,922,680

 

390,251,855

Liabilities and equity

 

 

 

 

Liabilities

 

 

 

 

Due to banks

24

8,817,535

 

11,810,607

Due to customers

25

341,169,450

 

304,448,455

Lease Liability

23

905,861

 

337,531

Derivative financial instruments

17

331,073

 

282,588

Other liabilities

27

15,070,029

 

12,923,926

Current Tax Liability

 

859,582

 

4,639,364

Other loans

26

7,746,946

 

3,272,746

Provisions

28

3,224,180

 

2,011,369

Total liabilities

 

378,124,656

 

339,726,586

Equity

 

 

 

 

Issued and paid in capital

29

14,776,813

 

14,690,821

Reserves

30

32,939,079

 

23,180,850

Reserve for employee stock ownership plan (ESOP)

30

1,064,648

 

963,152

Retained earnings

30

9,534,429

 

11,690,446

Total equity attributable to equity holders of the parent

 

58,314,969

 

50,525,269

Non-controlling interest

39

483,055

 

-

Total equity

 

58,798,024

 

50,525,269

Total liabilities and equity

 

436,922,680

 

390,251,855

 

 

 

 

 

 

 

 

 

 

The accompying notes from 1 to 42 form an integral part of these consolidated financial statements.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Hussein Abaza

 

Sherif Samy

CEO & Board member

 

Chairman

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated Statement of Changes in Shareholders' Equity

 

 

 

 

 

Dec. 31, 2019

Issued and paid in capital

Reserve for employee stock ownership plan (ESOP)

Retained earnings

Reserves

Total

Non-controlling interest

Total equity

 

 

 

 

 

 

 

 

 

 

Beginning balance at 1st of jan 2019

11,668,326

897,680

9,444,663

12,635,473

34,646,142

-

34,646,142

 

Total comprehensive income

-

-

10,033,494

-

10,033,494

-

10,033,494

 

Capital increase

3,022,495

-

-

-

3,022,495

-

3,022,495

 

Reserve for employee stock ownership plan (ESOP)

-

464,539

-

-

464,539

-

464,539

 

Dividend

-

-

(2,700,544)

-

(2,700,544)

-

(2,700,544)

 

Transferred to reserves

-

(399,067)

(5,087,167)

10,545,377

5,059,143

-

5,059,143

 

Balance at 31 December 2019

14,690,821

963,152

11,690,446

23,180,850

50,525,269

-

50,525,269

 

Beginning balance at 1st of Jan 2020

14,690,821

963,152

11,690,446

23,180,850

50,525,269

-

50,525,269

 

Total comprehensive income

-

-

9,335,044

-

9,335,044

(1,834)

9,333,210

 

Capital increase

85,992

-

-

-

85,992

-

85,992

 

Minority Interest share

-

-

-

-

-

485,779

485,779

 

Reserve for employee stock ownership plan (ESOP)

-

552,438

-

-

552,438

-

552,438

 

Dividend

-

-

(2,013,318)

-

(2,013,318)

-

(2,013,318)

 

Transferred to reserves

-

(450,942)

(9,477,743)

9,758,229

(170,456)

(890)

(171,346)

 

Balance at 31 December 2020

14,776,813

1,064,648

9,534,429

32,939,079

58,314,969

483,055

58,798,024

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated Statement of Cash Flow for the Year Ended December 31, 2020

 

 

 

 

 

 

 

 

Notes

Dec. 31, 2020

 

Dec. 31, 2019

 

 

 

EGP Thousands

 

EGP Thousands

 

 

 

 

 

 

 

 

 

Cash flow from operating activities

 

 

 

 

 

 

Profit before income tax from continued operations

 

14,333,195

 

14,767,380

 

 

Adjustments to reconcile net profit to net cash provided by operating activities

 

 

 

 

 

 

Fixed assets depreciation

 

924,667

 

587,662

 

 

Impairment charge for credit losses (Loans and advances to customers)

 

4,806,518

 

1,610,878

 

 

Other provisions charges

 

1,235,659

 

461,869

 

 

Impairment charge for other assets

 

69,217

 

(93,313)

 

 

Impairment charge for credit losses (due from banks)

 

7,081

 

9,503

 

 

Exchange revaluation differences for financial assets at fair value through OCI

 

249,642

 

1,593,030

 

 

Impairment charge for credit losses (financial investments)

 

205,182

 

(184,921)

 

 

Utilization of other provisions

 

(2,382)

 

(28,135)

 

 

Other provisions no longer used

 

(13,273)

 

(6,910)

 

 

Impairment of intangible assets

 

-

 

651,041

 

 

Exchange differences of other provisions

 

(7,193)

 

(110,062)

 

 

Released (Impairment) charges of investments in associates and subsidiaries

 

16,511

 

-

 

 

Profits from selling property, plant and equipment

 

(1,094)

 

(1,439)

 

 

(Profits) losses from selling financial investments

 

(1,018,469)

 

(497,894)

 

 

Shares based payments

 

552,438

 

464,539

 

 

Bank's share in the profits of associates

 

(22,426)

 

(1,135)

 

 

Operating profits before changes in working capital

 

21,335,273

 

19,222,093

 

 

 

 

 

 

 

 

 

Net decrease (increase) in working capital

 

 

 

 

 

 

Due from banks

 

(10,899,927)

 

(8,870,547)

 

 

Financial assets at fair value through P&L

 

58,822

 

2,318,924

 

 

Derivative financial instruments

 

16,109

 

(2,910)

 

 

Loans and advances to banks and customers

 

(5,020,609)

 

(14,533,328)

 

 

Other assets

 

568,988

 

163,933

 

 

Due to banks

 

(2,993,072)

 

4,550,788

 

 

Due to customers

 

36,720,995

 

19,151,586

 

 

Income tax obligations paid

 

(3,779,782)

 

(3,625,579)

 

 

Other liabilities

 

2,146,103

 

1,895,241

 

 

Net cash generated from operating activities

 

38,152,900

 

20,270,201

 

 

 

 

 

 

 

 

 

Cash flow from investing activities

 

 

 

 

 

 

 

 

 

 

 

 

 

Proceeds from Investments in associates.

 

750

 

-

 

 

Payment for purchases of property, plant, equipment and branches constructions

 

(1,091,829)

 

(1,303,181)

 

 

Proceeds from selling property, plant and equipment

 

1,094

 

1,439

 

 

Proceeds from redemption of financial assets at amortized cost

 

82,309,481

 

43,937,957

 

 

Payment for purchases of financial assets at amortized cost

 

(233,765)

 

(76,516,842)

 

 

Payment for purchases of financial assets at fair value through OCI

 

(117,787,925)

 

(50,954,311)

 

 

Proceeds from selling financial assets at fair value through OCI

 

54,137,187

 

54,855,966

 

 

Proceeds from selling property and equipment

 

194,722

 

-

 

 

Net cash generated from (used in) investing activities

 

17,529,715

 

(29,978,972)

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated Statement of Cash Flow for the Year Ended December 31, 2020

(Cont.)

 

 

 

 

 

 

 

 

Dec. 31, 2020

 

Dec. 31, 2019

 

 

 

 

EGP Thousands

 

EGP Thousands

 

 

 

 

 

 

 

 

 

Cash flow from financing activities

 

 

 

 

 

 

Received (Repaid) in long term loans

 

4,474,200

 

(448,783)

 

 

Dividend paid

 

(2,013,318)

 

(2,700,544)

 

 

Transferred from previous years' outstanding balances

 

85,992

 

105,413

 

 

Cash payments for lease (principle and interest)

 

(242,173)

 

-

 

 

Net cash generated from (used in) financing activities

 

2,304,701

 

(3,043,914)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net increase (decrease) in cash and cash equivalent during the year

 

57,987,316

 

(12,752,685)

 

 

Beginning balance of cash and cash equivalent

 

8,362,969

 

21,115,654

 

 

Cash and cash equivalent at the end of the year

 

66,350,285

 

8,362,969

 

 

 

 

 

 

 

 

 

Cash and cash equivalent comprise:

 

 

 

 

 

 

Cash and balances at the central bank

13

33,768,549

 

28,273,962

 

 

Due from banks

14

87,450,490

 

28,370,183

 

 

Treasury bills and other governmental notes

19

40,256,277

 

27,634,062

 

 

Obligatory reserve balance with CBE

13

(27,744,700)

 

(22,397,310)

 

 

Due from banks with maturities more than three months

 

(27,179,042)

 

(25,125,951)

 

 

Treasury bills with maturity more than three months

 

(40,201,289)

 

(28,391,977)

 

 

Total cash and cash equivalent

31

66,350,285

 

8,362,969

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACSSEUSAUEFSEEL
Date   Source Headline
26th Mar 20247:49 amRNSChanges in CIB's BOD - 25 March 2024
26th Mar 20247:00 amRNSOGM Resolutions - March 25th, 2024
26th Mar 20247:00 amRNSEGM Resolutions - March 25th, 2024
20th Feb 20247:00 amRNSNotice of AGM
20th Feb 20247:00 amRNSInvitation to Extraordinary GM (EGM)
16th Nov 20233:45 pmRNSCIB secures a USD 150M subordinated loan from EBRD
3rd Nov 20237:05 amRNS3Q23 Earnings Release
3rd Nov 20237:05 amRNS3rd Quarter Results
3rd Nov 20237:05 amRNS3rd Quarter Results - Consolidated
23rd Aug 20237:14 amRNSAppointment of Mr. Jawaid Mirza in CIB's BOD
24th Jul 20238:00 amRNSCIB 1H2023 Earnings Release
24th Jul 20238:00 amRNSCIB1H2023 Condensed Consolidated Financials
24th Jul 20238:00 amRNSCIB 1H2023 Separate Condensed Financial Statements
10th Jul 20238:00 amRNSCIB obtaining Long term loans from IFC
15th May 20237:00 amRNSCIB 1Q23 - Earnings Release
15th May 20237:00 amRNSCIB Q1-2023 Separate Financial Statements
15th May 20237:00 amRNSCIB 1Q23 Consolidated Financial Statements
20th Mar 20236:26 pmRNSCIB's FY22 IFRS 9 Financial Statements
20th Mar 20235:02 pmRNSResolutions Extraordinary General Assembly
20th Mar 20234:55 pmRNSResolutions Ordinary General Assembly (OGM)
16th Feb 20237:00 amRNSInvitation to CIB's Ordinary General Assembly
16th Feb 20237:00 amRNSInvitation to CIB's Extraordinary General Assembly
13th Feb 20237:00 amRNSCIB - 4Q 2022 Earnings Release
13th Feb 20237:00 amRNSCIB Q4-2022 Separate Financial Statements
13th Feb 20237:00 amRNSCIB Q4-2022 Consolidated Financial Statements
30th Jan 20237:00 amRNSCIB fully acquires MayFair CIB (Kenya)-Replacement
27th Jan 20235:51 pmRNSCIB fully acquires Mayfair CIB
11th Jan 20234:41 pmRNSSecond Price Monitoring Extn
11th Jan 20234:35 pmRNSPrice Monitoring Extension
8th Dec 202212:25 pmRNSPress Release dated 8 December 2022
22nd Nov 20228:14 amRNSChanges in CIB's Board of Directors
4th Nov 20227:00 amRNS3rd Quarter 2022 (Earnings Release)
4th Nov 20227:00 amRNSBoard Resolutions Summary 3 Nov 2022
4th Nov 20227:00 amRNS3rd Quarter 2022 Results (Separate)
4th Nov 20227:00 amRNS3rd Quarter 2022 Results (Consolidated)
15th Aug 20227:00 amRNSChange in CIB's CEO Retail Banking
25th Jul 20227:00 amRNSCIB 1H2022 Condensed Separate Financial Results
25th Jul 20227:00 amRNSCIB1H2022 Earnings Release
25th Jul 20227:00 amRNSCIB1H2022 Consolidated Condensed Financial Results
19th May 20223:09 pmRNSChange in CIB's Board of Directors
29th Apr 202212:17 pmRNSCIB FY 2021 IFRS Annual Financial Report
19th Apr 20227:00 amRNSCIB 1Q2022 Earnings Release
19th Apr 20227:00 amRNSCIB1Q2022 Condensed Consolidated Financial results
19th Apr 20227:00 amRNSCIB 1Q2022 Condensed Separate Results
28th Mar 20227:00 amRNSCIB's AGM Resolutions Summary
10th Mar 20224:41 pmRNSSecond Price Monitoring Extn
10th Mar 20224:36 pmRNSPrice Monitoring Extension
9th Mar 20224:36 pmRNSPrice Monitoring Extension
4th Mar 20227:00 amRNSInvitation toCIB Ordinary General Assembly Meeting
22nd Feb 20227:00 amRNSCIB FY 2021 Separate Financial results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.